Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M. P. H. van de Waarenburg"'
Autor:
M.M.J. van Greevenbroek, Nordin M J Hanssen, Casper G. Schalkwijk, M Piazza, M. P. H. van de Waarenburg, Frederik Persson, P Hovind, H. H. Parving, Peter Rossing, Jean L.J.M. Scheijen, Coen D.A. Stehouwer
Publikováno v:
Diabetic Medicine
Diabetic Medicine, 38(9):14405. Wiley
Piazza, M, Hanssen, N M J, Persson, F, Scheijen, J L, van de Waarenburg, M P H, van Greevenbroek, M M J, Rossing, P, Hovind, P, Stehouwer, C D A, Parving, H H & Schalkwijk, C G 2021, ' Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria : An IRMA2 sub-study ', Diabetic Medicine, vol. 38, no. 9, e14405 . https://doi.org/10.1111/dme.14405
Diabetic medicine, 38(9):e14405. Wiley-Blackwell
Diabetic Medicine, 38(9):14405. Wiley
Piazza, M, Hanssen, N M J, Persson, F, Scheijen, J L, van de Waarenburg, M P H, van Greevenbroek, M M J, Rossing, P, Hovind, P, Stehouwer, C D A, Parving, H H & Schalkwijk, C G 2021, ' Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria : An IRMA2 sub-study ', Diabetic Medicine, vol. 38, no. 9, e14405 . https://doi.org/10.1111/dme.14405
Diabetic medicine, 38(9):e14405. Wiley-Blackwell
Aim: Angiotensin receptor blockers (ARBs) reduce vascular complications in diabetes independently of blood pressure. Experimental studies suggested that ARBs may restore the detoxifying enzyme glyoxalase 1, thereby lowering dicarbonyls such as methyl
Autor:
Miranda T. Schram, Carroll A.B. Webers, M.M.J. van Greevenbroek, Casper G. Schalkwijk, Alphons J.H.M. Houben, Ronald M.A. Henry, C.J.H. van der Kallen, Coen D.A. Stehouwer, Nicolaas C. Schaper, Tos T. J. M. Berendschot, Koen D. Reesink, M. P. H. van de Waarenburg, Jean L.J.M. Scheijen, Nordin M J Hanssen
Publikováno v:
Diabetes & Metabolism, 47(1):101148. Elsevier Masson s.r.l.
Diabetes & metabolism, 47(1):101148. Elsevier Masson
Diabetes & Metabolism, 47(1):101148. Elsevier Masson
Diabetes & metabolism, 47(1):101148. Elsevier Masson
Diabetes & Metabolism, 47(1):101148. Elsevier Masson
Aims: Reactive dicarbonyl compounds, such as methylglyoxal (MGO), rise during an oral glucose tolerance test (OGTT), particularly in (pre)diabetes. Fasting MGO levels are associated with chronic kidney disease (CKD) and cardiovascular disease (CVD) i